Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules.
AUTHORS
Maiga
AW ,
Deppen
SA ,
Mercaldo
SF ,
Blume
JD ,
Montgomery
C ,
Vaszar
LT ,
Williamson
C ,
Isbell
JM ,
Rickman
OB ,
Pinkerman
R ,
Lambright
ES ,
Nesbitt
JC ,
Grogan
EL ,
. JAMA surgery. 2017 11 8; ().
- PMID: 29117314 [PubMed].
ABSTRACT
Clinicians rely heavily on fluorodeoxyglucose F18-labeled positron emission tomography (FDG-PET) imaging to evaluate lung nodules suspicious for cancer. We evaluated the performance of FDG-PET for the diagnosis of malignancy in differing populations with varying cancer prevalence.
Clinicians rely heavily on fluorodeoxyglucose F18-labeled positron emission tomography (FDG-PET) imaging to evaluate lung nodules suspicious for cancer. We evaluated the performance of FDG-PET for the diagnosis of malignancy in differing populations with varying cancer prevalence.
Tags: Alumni Publications 2017